524558 logo

Neuland Laboratories Limited Stock Price

BSE:524558 Community·₹164.5b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 9 Fair Values set on narratives written by author

524558 Share Price Performance

₹12,819.35
1858.75 (16.96%)
₹18,865.25
Fair Value
₹12,819.35
1858.75 (16.96%)
32.0% undervalued intrinsic discount
₹18,865.25
Fair Value
Price ₹12,819.35
AnalystConsensusTarget ₹18,865.25

524558 Community Narratives

AnalystConsensusTarget·
Fair Value ₹18.87k 32.0% undervalued intrinsic discount

524558: Leadership Changes And Board Decisions Will Shape The Next Phase

1users have liked this narrative
0users have commented on this narrative
4users have followed this narrative

Trending Discussion

Updated Narratives

524558 logo

524558: Peptide Partnership Progress And Upcoming Results Date Will Support Future Upside Potential

Fair Value: ₹18.87k 32.0% undervalued intrinsic discount
4 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Exceptional growth potential with flawless balance sheet.

1 Risk
2 Rewards

Neuland Laboratories Limited Key Details

₹15.8b

Revenue

₹8.0b

Cost of Revenue

₹7.8b

Gross Profit

₹6.0b

Other Expenses

₹1.8b

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
139.62
49.33%
11.37%
16.3%
View Full Analysis

About 524558

Founded
1984
Employees
1794
CEO
Davuluri Rao
WebsiteView website
www.neulandlabs.com

Neuland Laboratories Limited engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. It also provides custom manufacturing solutions, as well as peptide synthesis services. Neuland Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Recent 524558 News & Updates

Recent updates

No updates